Tradestie Institutional Equity Comparison Engine

BDRX vs SLMT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BDRX Overall Edge

BDRX Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus SLMT at N/M Forward P/E and -4271.3% operating margin (+929.8% YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLMT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BDRX N/M vs SLMT N/M Fwd P/E
Growth & Margin Winner BDRX
Op Margin 0.0% vs -4271.3% ยท YoY -64.1% vs +929.8%
Momentum & Technical Winner BDRX
1Y -51.4% vs -61.3% ยท 52W Pos 18% vs 26%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap $1.0M
1M Return +352.9%
1Y Return -51.42%
Forward P/E N/M
Unified AI Score
36.0 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
SLMT US Equity
SLMT
Institutional Equity
$2.24
-13.85% 1D
Market Cap $28.6M
1M Return -29.78%
1Y Return -61.31%
Forward P/E N/M
Unified AI Score
43.0 / 100 HOLD
Tech 33.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BDRX -51.42% SLMT -61.31% Spread: +9.89 pp (BDRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BDRX TTM Op. Margin: 0.0% SLMT TTM Op. Margin: -4271.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs SLMT. Trailing 12-month operating profitability (BDRX 0.0% vs SLMT -4271.3%) and valuation multiples (BDRX N/M vs SLMT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BDRX (2) vs SLMT (5)
Institutional Metric BDRX SLMT Criterion Row Winner
Market Capitalization Scale $1.0M $28.6M Larger Scale SLMT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -64.1% +929.8% Higher Growth SLMT
Operating Margin (TTM) Profitability 0.0% -4271.3% Higher Margin BDRX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -42.0% -795.8% Higher ROE BDRX
52-Week Range Position Momentum 18% ($0โ€“$9) 26% ($1โ€“$7) Stronger Trend SLMT
Beta / 30D Volatility Risk Regime 5.62ฮฒ ยท 2621% Vol 7.98ฮฒ ยท 107% Vol Lower Realized Risk SLMT
Unified Institutional Score Composite Signal 36.0 / 100 (SELL) 43.0 / 100 (HOLD) Higher Composite SLMT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BDRX vs SLMT Buy Guide
BDRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BDRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLMT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SLMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BDRX nor SLMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.